Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Cardiovascular and metabolic benefits persist, and serious side effects remain rare
El-Hattab, AW, Adesina, AM, Jones, J, Scaglia, F 2015, MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options, Molecular genetics and metabolism , vol
PMC 2696340
Compared to dual agonists such as Tirzepatide and single-pathway compounds like Semaglutide, Retatrutide represents a broader multi-pathway research model
US$ 22.41
US$ 29.95
US$ 22.81
US$ 21.22
US$ 27.64
US$ 23.96
US$ 24.58
